<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03230565</url>
  </required_header>
  <id_info>
    <org_study_id>41434</org_study_id>
    <nct_id>NCT03230565</nct_id>
  </id_info>
  <brief_title>Continuous Infusions vs Scheduled Bolus Infusions</brief_title>
  <official_title>A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare continuous infusions to bolus infusions and there affect on post-surgical pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regional anesthetic techniques are an integral part to many anesthetic approaches, providing
      both intraoperative and postoperative anesthesia and analgesia. Regional anesthesia
      peripheral nerve blocks have been shown to reduce postoperative pain and improve measures
      such as opioid requirements and readiness for discharge. By using a catheter technique for
      continuous peripheral nerve blocks, analgesia can be extended well into post-operative days 2
      and 3, further extending these benefits. Historically these catheters have implemented a
      continuous dosing regimen of local anesthetic, but increasingly there is evidence of improved
      analgesic outcomes without adverse effects by using a scheduled bolus dosing regimen. Many
      institutions have implemented this new protocol for catheter dosing. The beneficial effect of
      scheduled bolus dosing has not been studied in all blocks and all surgical procedures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Comparison of two groups: 1) Continuous infusion group 2) Bolus Infusion group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Investigators and participants will be masked to treatment group. Care providers will be necessarily unmasked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post-surgical pain</measure>
    <time_frame>2-3 days after surgery</time_frame>
    <description>Patients will rate their pain on a 0-10 scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>2-3 days after surgery</time_frame>
    <description>Pain medications consumed by patients will be collected</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Surgical Procedure, Unspecified</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Continuous Infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local anesthetic medication (Ropivacaine 0.2%) is provided at a continuous basal rate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intermittent Bolus Infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local anesthetic medication (Ropivacaine 0.2%) is provided in scheduled, intermittent boluses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Patient will be given a continuous infusion of local anesthetic.</description>
    <arm_group_label>Continuous Infusion</arm_group_label>
    <other_name>Continuous infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Patient will be given a scheduled intermittent bolus of local anesthetic.</description>
    <arm_group_label>Intermittent Bolus Infusion</arm_group_label>
    <other_name>Bolus Infusion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Enrollment will be offered to adult patients with ASA physical status
        I, II, or III, presenting for nerve block catheters for post-operative analgesia.

        -

        Exclusion Criteria: Exclusion criteria will include: pregnancy, incarceration, age &lt;18, BMI
        &gt;35, pre-operative opioid use &gt;30 mg morphine equivalents per day, inability to communicate
        with investigators by telephone, and pre-existing neuropathy of the operative extremity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Louis-Horn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aaron J Deng, BS</last_name>
    <phone>408-914-5494</phone>
    <email>adeng1@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Archana Verma</last_name>
    </contact>
    <investigator>
      <last_name>Jean Louis-Horn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 24, 2017</study_first_submitted>
  <study_first_submitted_qc>July 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2017</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Jean-Louis Horn</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

